The Beckley Foundation was set up in 1998 by its Director Amanda Feilding. Since then it has been at the frontier of Global Drug Policy Reform and Scientific Research into the potential benefits of psychoactive substances. The Beckley Foundation is unique in combining a pioneering scientific research programme with being a much respected international drug policy think-tank, which holds special consultative status at the UN.
‚ÄĘ Policy Programme: work to reform national and international drug policies using evidence-based scientific research. The Foundation has always advocated a move away from the current prohibitionist approach towards policies based on health, harm-reduction, cost-effectiveness and the respect of human rights.
‚ÄĘ Scientific Programme: undertakes pioneering research on how psychoactive substances work in the brain, thereby uncovering their potential benefits. Our current scientific projects include research on Psilocybn, LSD, MDMA, Ayahuasca and Cannabis.